Technology & Innovation

SHERIDAN, WYOMING - March 31, 2026 - Early-stage medtech companies could regain a key non-dilutive funding route in 2026 after the Senate passed legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, reducing uncertainty that has persisted since the programs' authorization lapsed on September 30, 2025. AdvaMed said the Senate action restores momentum for grants that support early research and development at startups and small manufacturers, and it urged the House of Representatives to move quickly on passage. The association framed the programs as an important bridge for companies that struggle to finance next-generation device development before products reach patients or later-stage commercial milestones.

SHERIDAN, WYOMING - March 31, 2026 - Grinding manufacturers face a more data-driven operating model in 2026 as cooling lubricant management moves from a maintenance task into a direct lever for energy use, surface quality, uptime and scrap reduction. VDW highlights this shift through research and industrial practice around requirement-based coolant supply, where sensor data, standardized machine connectivity and cloud-based service platforms are used to stabilize grinding conditions and support more autonomous production.

SHERIDAN, WYOMING - March 31, 2026 - Health organizations planning 2026 research participation in Europe gain a new route to influence project design, allocate in-kind resources, and support proposals without taking on full private-member status in the Innovative Health Initiative. MedTech Europe points to an 11 February 2026 webinar hosted by the IHI Office, focused on the contributing partner category for organizations that are not affiliated with an IHI private industry member, as well as organizations affiliated with a private member that need to understand how contributing partners can support proposals. The session is positioned around practical participation questions rather than broad program promotion, including eligibility, application steps, contribution rules, and common mistakes.

SHERIDAN, WYOMING - April 4, 2026 - Research teams and organizations working on animal feed and flour milling innovation now have a structured path to external financing through the Victam Foundation's 2026 Call for Funding, with final project selections and award decisions scheduled for completion by early June 2026 at Victam International in Utrecht, The Netherlands.

Funding cycle overview

The Victam Foundation opened its 2026 Call for Funding submission window on September 12, 2025, accepting project proposals through January 31, 2026. The call targets researchers, organizations, and innovators developing projects that advance the animal feed and flour milling industries. There are no submission fees, and proposals must be submitted via the foundation's online requesting form. Applications must include a detailed project description and an expected budget; the foundation reserves the right to request additional documentation where necessary.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.

SHERIDAN, WYOMING - March 13, 2026 - Roche has reported positive Phase II results for petrelintide, an amylin analog being developed for people living with overweight and obesity. According to the company, petrelintide delivered up to 10.7% mean body weight reduction at week 42 compared with 1.7% for placebo, with a p-value of less than 0.001. Roche also said the maximally effective dose showed placebo-like tolerability, with no vomiting cases and no treatment discontinuations due to gastrointestinal adverse events. For the obesity treatment market, the update is relevant because efficacy and tolerability remain central to prescribing, adherence and competitive positioning.

SHERIDAN, WYOMING - December 30, 2025 - CPGIO says it has expanded its digital retail footprint by launching on multiple major marketplaces, positioning the company to support consumer brands with broader omnichannel distribution across a mix of mass, specialty, and B2B wholesale platforms.

Multi-marketplace expansion and timing

The company reported successful launches across Nordstrom, Chewy, Lowe's, Faire, and Best Buy, with the rollout beginning in November 2025. For consumer brands, the announcement signals a continued push toward diversified third-party marketplace presence as a growth lever, particularly as retailers extend marketplace models beyond core categories. For service providers and operators, the business impact typically centers on onboarding speed, catalog and content compliance, inventory synchronization, and the ability to manage pricing and pack-out strategy consistently across channels.

SHERIDAN, WYOMING - December 30, 2025 - ALS Northwest says it increased its financial investment in ALS research throughout 2025, expanding support for new approaches in treatment, prevention, and scientific understanding while joining a multi-organization funding initiative intended to strengthen the overall research pipeline.

Research investment strategy and portfolio focus

ALS Northwest framed its 2025 approach as a scaled-up commitment to research designed to accelerate innovation in amyotrophic lateral sclerosis (ALS). The organization said its efforts span multiple stages of scientific discovery, with an emphasis on enabling new approaches that could move the field forward. For research stakeholders, the operational question is not only how much is invested, but how efficiently funding is converted into validated findings, new targets, and ultimately clinical progress.

SHERIDAN, WYOMING - December 27, 2025 - United Airlines has rolled out a new set of mobile app capabilities designed to reduce airport friction, improve real-time transparency, and shift more travel support into self-service workflows during peak travel demand.

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber is sharpening its focus on electric-vehicle OEM business in the automotive & mobility sector, confirming that its GEOLANDAR X-CV highway terrain tire is now factory-equipped on the newly updated Lexus RZ battery-electric SUV for the North American market. The 235/50R20 100V fitment positions Yokohama's SUV-focused GEOLANDAR line squarely in the premium BEV arena, supporting automakers' push for quieter, more efficient and more durable EV drivetrains.

Premium EV SUV fitment strengthens North American footprint